Search results
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 1 day agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 24 hours agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 1 day agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 2 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock. This is an increase ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 1 day agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 2 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
BioNTech SE Stock Price Today | BVMF B1NT34 Live Ticker - Investing.com
Investing.com· 3 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 18 hours agoMcElhaugh’s statement that Arbutus doesn’t anticipate further at-the-market share issuances this year due to its substantial cash balance and liquidity....
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 19 hours agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 2 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...